The Centre for Trauma Sciences Research has been launched by Birmingham Health Partners members, aiming to advance the development of new technologies and clinical treatments for trauma patients.
Led by Ann Logan, Professor of Molecular Neuroscience at the University of Birmingham’s Institute of Inflammation and Ageing, the centre will focus on enabling the translational pathway from conception towards clinical adoption.
“Worldwide, trauma kills six million people every year and traumatic injury is the biggest killer of people under the age of 40, as well as being the greatest cause of permanent disability.
“With an ageing population, it is also now a leading cause of death and morbidity for elderly people, second only to Alzheimer’s and Parkinson’s disease.
“Each year in the UK over 16,000 people die from road traffic collisions, interpersonal violence or falls from height.
“Trauma research is vital to help us understand how the body responds to injury, leading to improvements and innovations in diagnosis, resuscitation, surgery and intensive care.
“Only through research can we reduce deaths from trauma and reduce suffering for all trauma survivors.
“We are delighted to open this new centre, which will provide a focal point that links pre-clinical and clinical researchers working across wide-ranging translational trauma science projects.”
Professor Ann Logan
The centre will be supported by Professor Liam Grover through his role as Director of the Healthcare Technologies Institute, based within the Institute of Translational Medicine, which is advancing new technologies and treatments that encourage better tissue healing and rehabilitation tools to ensure people live longer, healthier and happier lives.
Close work will also take place with the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC), the NIHR Trauma Management MedTech Co-Operative, the Scar Free Foundation Centre for Conflict Wound Research (all of which are based in the ITM), the Physical Sciences for Health Centre, and the pharmaceutical and biotech industry.
The centre will also act as the hub of a national network of trauma science research laboratories, becoming the ‘go to’ centre for near-patient testing, consultancy, information and access to key academic, commercial, regulatory and clinical partnerships.
In addition, it will build significant research capacity by training a substantive cohort of early career trauma research scientists, both clinical and non-clinical, who will drive future trauma research to address a research capacity deficit in trauma in the UK.
